Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Scorpius Holdings Inc (EM) SCPX

Healthcare Biotechnology
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream... see more

Recent & Breaking News (EXPM:SCPX)

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

Business Wire May 14, 2025

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

GlobeNewswire May 5, 2025

Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining

GlobeNewswire April 30, 2025

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

GlobeNewswire April 21, 2025

Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives

GlobeNewswire February 26, 2025

Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer(TM)

GlobeNewswire January 22, 2025

Scorpius Holdings Cancels Planned Reverse Stock Split

GlobeNewswire January 17, 2025

Scorpius Holdings Announces Reverse Stock Split

GlobeNewswire January 16, 2025

Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model

GlobeNewswire November 19, 2024

Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability

GlobeNewswire November 14, 2024

Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement

GlobeNewswire November 4, 2024

Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually

GlobeNewswire October 31, 2024

Scorpius Holdings Announces Partnership with U.S. Biotech Company

GlobeNewswire October 22, 2024

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats

GlobeNewswire October 2, 2024

Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities

GlobeNewswire September 30, 2024

Scorpius Holdings Commends the U.S. House of Representatives' Passage of the BIOSECURE Act

GlobeNewswire September 12, 2024

Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA

GlobeNewswire September 9, 2024

Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow

GlobeNewswire August 26, 2024

Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024

GlobeNewswire August 20, 2024

Scorpius Holdings, Inc. Announces Closing of Public Offering

GlobeNewswire August 19, 2024